Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sutent for Recurrent Anaplastic Astrocytoma and Glioblastoma
NCT00606008Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Mar 2007
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in anaplastic astrocytoma (AA), glioblastoma multiforme (GBM), sponsored by Moffitt Cancer Center. Started Mar 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
anaplastic astrocytoma (AA)glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00606008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00606008.